Eligibility Prostate Cancer NCT02137746

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
male 18 years and older
Descrição

ID.1

Tipo de dados

boolean

histologically confirmed prostate adenocarcinoma stage pathological tumor-2 (pt2)
Descrição

ID.2

Tipo de dados

boolean

post radical primary prostatectomy
Descrição

ID.3

Tipo de dados

boolean

completion of dcvac/pca arm in study sp003, without objective progression of the disease
Descrição

ID.4

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior androgen deprivation therapy for prostate cancer
Descrição

ID.5

Tipo de dados

boolean

peripheral neuropathy of common toxicity criteria (ctc) grade 2 or greater
Descrição

ID.6

Tipo de dados

boolean

other uncontrolled intercurrent illness
Descrição

ID.7

Tipo de dados

boolean

treatment with immunotherapy against pca
Descrição

ID.8

Tipo de dados

boolean

clinically significant cardiovascular disease
Descrição

ID.9

Tipo de dados

boolean

active autoimmune disease requiring treatment
Descrição

ID.10

Tipo de dados

boolean

Similar models

Eligibility Prostate Cancer NCT02137746

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male 18 years and older
boolean
ID.2
Item
histologically confirmed prostate adenocarcinoma stage pathological tumor-2 (pt2)
boolean
ID.3
Item
post radical primary prostatectomy
boolean
ID.4
Item
completion of dcvac/pca arm in study sp003, without objective progression of the disease
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
prior androgen deprivation therapy for prostate cancer
boolean
ID.6
Item
peripheral neuropathy of common toxicity criteria (ctc) grade 2 or greater
boolean
ID.7
Item
other uncontrolled intercurrent illness
boolean
ID.8
Item
treatment with immunotherapy against pca
boolean
ID.9
Item
clinically significant cardiovascular disease
boolean
ID.10
Item
active autoimmune disease requiring treatment
boolean